---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-258662"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:13:56.177778+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Edwards Lifesciences CFO Scott Ullem to step down by mid-2026; successor search underway

## Summary
- CFO Scott Ullem informed company on Oct. 30, 2025 of decision to transition by mid-2026.
- Company initiating selection process to appoint a new CFO; Ullem will serve in advisory role after appointment.
- Plan described as a planned transition to ensure continuity and smooth handoff.

## SEC filing metadata
- accession: 0001193125-25-258662
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000119312525258662/0001193125-25-258662-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000119312525258662/d50813d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-258662
- JSON: https://secwatch.observer/filing/0001193125-25-258662.json
- Plain text: https://secwatch.observer/filing/0001193125-25-258662.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.